BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 32856697)

  • 1. The future of precision medicine: towards a more predictive personalized medicine.
    Elemento O
    Emerg Top Life Sci; 2020 Sep; 4(2):175-177. PubMed ID: 32856697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope.
    Aghaei Meybodi HR; Hasanzad M; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):166-174. PubMed ID: 28282717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
    Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
    Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals.
    Govender R; Abrahmsén-Alami S; Larsson A; Folestad S
    Eur J Pharm Biopharm; 2020 Apr; 149():58-76. PubMed ID: 31982577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digging Deeper into Precision/Personalized Medicine: Cracking the Sugar Code, the Third Alphabet of Life, and Sociomateriality of the Cell.
    Özdemir V; Arga KY; Aziz RK; Bayram M; Conley SN; Dandara C; Endrenyi L; Fisher E; Garvey CK; Hekim N; Kunej T; Şardaş S; Von Schomberg R; Yassin AS; Yılmaz G; Wang W
    OMICS; 2020 Feb; 24(2):62-80. PubMed ID: 32027574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy?
    Franks PW; Poveda A
    Diabetologia; 2017 May; 60(5):784-792. PubMed ID: 28124081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual Biomarkers Using Molecular Personalized Medicine Approaches.
    Zenner HP
    ORL J Otorhinolaryngol Relat Spec; 2017; 79(1-2):7-13. PubMed ID: 28231575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized Management of Cardiovascular Disorders.
    Jain KK
    Med Princ Pract; 2017; 26(5):399-414. PubMed ID: 28898880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized Medicine: What's in it for Rare Diseases?
    Schee Genannt Halfmann S; Mählmann L; Leyens L; Reumann M; Brand A
    Adv Exp Med Biol; 2017; 1031():387-404. PubMed ID: 29214584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive biomarkers for type 2 of diabetes mellitus: Bridging the gap between systems research and personalized medicine.
    Kraniotou C; Karadima V; Bellos G; Tsangaris GT
    J Proteomics; 2018 Sep; 188():59-62. PubMed ID: 29518575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy.
    Jørgensen JT
    Oncologist; 2019 Jul; 24(7):e432-e440. PubMed ID: 30940745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized medicine- future of diagnosis and management of T2DM.
    Verma S; Rizvi S; Abbas M; Raza T; Mahdi F
    Diabetes Metab Syndr; 2019; 13(4):2425-2430. PubMed ID: 31405654
    [No Abstract]   [Full Text] [Related]  

  • 13. Precision medicine for managing diabetes.
    Klonoff DC
    J Diabetes Sci Technol; 2015 Jan; 9(1):3-7. PubMed ID: 25550409
    [No Abstract]   [Full Text] [Related]  

  • 14. How Recent Advances in Genomics Improve Precision Diagnosis and Personalized Care of Maturity-Onset Diabetes of the Young.
    Vaxillaire M; Froguel P; Bonnefond A
    Curr Diab Rep; 2019 Aug; 19(9):79. PubMed ID: 31385057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Medicine and Personalized Medicine in Cardiovascular Disease.
    Currie G; Delles C
    Adv Exp Med Biol; 2018; 1065():589-605. PubMed ID: 30051409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Medicine and the Changing Landscape of Research Ethics.
    Hammer MJ
    Oncol Nurs Forum; 2016 Mar; 43(2):149-50. PubMed ID: 26906126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Medicine Is Not Just Genomics: The Right Dose for Every Patient.
    Peck RW
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():105-122. PubMed ID: 28961067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
    La Thangue NB; Kerr DJ
    Nat Rev Clin Oncol; 2011 Aug; 8(10):587-96. PubMed ID: 21862978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Individualized to Personalized Medicine in Diabetes: An Expert Overview.
    Mohan V; Das AK; Mukherjee JJ; Seshadri K; Jha S; Kalra S
    J Assoc Physicians India; 2019 Sep; 67(9):78-82. PubMed ID: 31561694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.